Frontier Cancer Medicine Guide
Author | : Karol Sikora |
Publisher | : |
Total Pages | : 96 |
Release | : 2003-09-01 |
Genre | : |
ISBN | : 9780954579401 |
Download Frontier Cancer Medicine Guide Book in PDF, ePub and Kindle
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Frontier Cancer Medicine Guide PDF full book. Access full book title Frontier Cancer Medicine Guide.
Author | : Karol Sikora |
Publisher | : |
Total Pages | : 96 |
Release | : 2003-09-01 |
Genre | : |
ISBN | : 9780954579401 |
Author | : World Health Organization |
Publisher | : |
Total Pages | : 0 |
Release | : 1981 |
Genre | : Cancer pain |
ISBN | : |
Author | : Matt Neuburg |
Publisher | : O'Reilly Media |
Total Pages | : 634 |
Release | : 1998 |
Genre | : Database management |
ISBN | : |
The first book devoted exclusively to teaching and documenting Userland Frontier, a collection of powerful, pre-written scripts for total web site management, this book teaches readers Frontier from the ground up. The guide is packed with examples, advice, tricks, and tips.
Author | : Atta-ur-Rahman |
Publisher | : Bentham Science Publishers |
Total Pages | : 322 |
Release | : 2021-12-03 |
Genre | : Science |
ISBN | : 1681089327 |
Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics: - Key data management elements in clinical trials for oncological therapeutics - Prospects for therapeutic targeting of microRNAs in brain tumors - Breast cancer vaccines: current status and future approach - Desmocollin-3 and cancer - MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53 - Towards targeted therapy: anticancer agents targeting cell organelle mitochondria - Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults.
Author | : Karen Glanz |
Publisher | : |
Total Pages | : 52 |
Release | : 1997 |
Genre | : Health behavior |
ISBN | : |
Author | : Atta-ur-Rahman |
Publisher | : Bentham Science Publishers |
Total Pages | : 348 |
Release | : 2015-11-27 |
Genre | : Medical |
ISBN | : 1681082012 |
Frontiers in Clinical Drug Research – HIV is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the eBook series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research. The second volume of this series features 5 chapters that cover a variety of topics including: - HIV-1 Integrase Inhibitors - HIV in vaginal mucosa - Long-Acting Antiretroviral Formulations -The world of people living with HIV/AIDS.
Author | : Kapil Mehta |
Publisher | : Springer Science & Business Media |
Total Pages | : 372 |
Release | : 2009-06-12 |
Genre | : Medical |
ISBN | : 0387894454 |
It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosisand 565,650individualswould die of cancer (Jemal et al. 2008).Since the vast majority of patients dying of cancer will have had anticancer therapy, both c- ventional chemotherapy and novel targeted therapy, it can be concluded that these patients are dying with drug resistant cancer. The term multidrug resistance is also apt – in that these patients die after having undergone multiple rounds of different and structurally unrelated cancer therapies. However, for some, the concept of m- tidrug resistance is a worn out idea, stemming from disappointment with the drug resistancereversalstrategiesthatwerecarriedoutinthe1990susingpumpinhibitors to block drug resistance mediated by P-glycoprotein, product of the MDR-1 gene. However, if one takes the larger de?nition – multidrug resistance as simultaneous resistance to multiple structurally unrelated anticancer therapies – its existence c- not be denied. The purpose of this book is to explore new concepts related to drug resistance in cancer, including resistance to the new molecularly targeted agents. Perhaps new terminology is needed for resistance that occurs following therapy with the targeted agents: Novel Targeted Agent Resistance (NTR). Alternatively, we can return to the original de?nition of multidrug resistance as simply the res- tance to multipleagents that occurs in the course of normalcancer progression.This resistance is likely to be mediated by many factors.
Author | : Giuseppe Giaccone |
Publisher | : Frontiers Media SA |
Total Pages | : 213 |
Release | : 2019-07-01 |
Genre | : |
ISBN | : 288945939X |
Foreword from the Field Chief Editor, Giuseppe Giaccone Once again Frontiers in Oncology has started the year on a positive note, breaking previous records for submissions and publications, as well as the number of Research Topic article collections posted. The journal continues to grow in size, adding an 18th section focusing on Cancer Metabolism, led by Michael Lisanti and Ubaldo Martinez-Outschoorn, and has brought on a total of five new Chief Editors. Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different disciplines. With an array of papers looking at everything from translational research to association studies and clinical trial results, Frontiers in Oncology continues to publish high-quality research from researchers around the world. Many of the recently posted Research Topics in the journal focus on early diagnosis and prevention, as well as the importance of survivorship studies and outcomes of cancer treatment. Consideration of such aspects of cancer research and treatment is pivotal in the global effort towards increased survival rates and improved quality of life. With ASCO 2019 marking the end of Q1 and the transition into Q2, the journal looks forward to the rest of the year, and continuing to play an active role in the research community. Giuseppe Giaccone
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 455 |
Release | : 2008-03-19 |
Genre | : Medical |
ISBN | : 0309134161 |
Cancer care today often provides state-of-the-science biomedical treatment, but fails to address the psychological and social (psychosocial) problems associated with the illness. This failure can compromise the effectiveness of health care and thereby adversely affect the health of cancer patients. Psychological and social problems created or exacerbated by cancer-including depression and other emotional problems; lack of information or skills needed to manage the illness; lack of transportation or other resources; and disruptions in work, school, and family life-cause additional suffering, weaken adherence to prescribed treatments, and threaten patients' return to health. Today, it is not possible to deliver high-quality cancer care without using existing approaches, tools, and resources to address patients' psychosocial health needs. All patients with cancer and their families should expect and receive cancer care that ensures the provision of appropriate psychosocial health services. Cancer Care for the Whole Patient recommends actions that oncology providers, health policy makers, educators, health insurers, health planners, researchers and research sponsors, and consumer advocates should undertake to ensure that this standard is met.
Author | : Monica Castiglione |
Publisher | : Springer Science & Business Media |
Total Pages | : 483 |
Release | : 2009-07-11 |
Genre | : Medical |
ISBN | : 0387751157 |
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.